Skip to main content

Biotechnology Value Fund L P's Form 4 filing

Third Harmonic Bio, Inc. (THRD) · filed Dec 22, 2022

Accession no.
0001193805-22-001774
Filed
Dec 22, 2022, 6:49 PM ET
Trade date
Dec 20, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $879.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Biotechnology Value Fund L PCIK 0000918923Other: See Explanation of Responses
BVF Partners L PCIK 000105594710% Owner
BVF IncCIK 000105680710% Owner
Biotechnology Value Fund II LPCIK 0001102444Other: See Explanation of Responses
Lampert Mark NCIK 000123384010% Owner
Biotechnology Value Trading Fund OS LPCIK 0001660683Other: See Explanation of Responses
BVF Partners OS Ltd.CIK 0001660684Other: See Explanation of Responses
BVF I GP LLCCIK 0001803805Other: See Explanation of Responses
BVF II GP LLCCIK 0001803806Other: See Explanation of Responses
BVF GP Holdings LLCCIK 0001803809Other: See Explanation of Responses

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 20, 2022Common StockPPurchaseAcquired+116,635$4.11+$479,206.562,332,638Direct
Dec 20, 2022Common StockPPurchaseAcquired+87,831$4.11+$360,862.451,764,220Direct
Dec 20, 2022Common StockPPurchaseAcquired+9,597$4.11+$39,430.23241,309Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)